Assessment of Ventricular Septal Defect Size and Morphology by Three-Dimensional Transthoracic Echocardiography

Hadeed, Khaled; Hascoët, Sébastien; Amadieu, Romain; Karsenty, Clément; Cuttone, Fabio; Léobon, Bertrand; Dulac, Yves; Acar, Philippe

doi:10.1016/j.echo.2016.04.012

Cited by 22 publications

(7 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Although the diagnostic value of traditional 3DE has been confirmed for relatively common septal defects ( Saric et al, 2010 ; Charakida et al, 2014 ; Cossor et al, 2015 ; Hadeed et al, 2016 ), TrueVue plus a light source makes not only the defect boundary clearer, but also makes the range for the soft rim more visible. In TrueVue Glass, adjusting the transparency highlights the origin and extent of an atrial or ventricular shunt.…”

Section: Discussionmentioning

confidence: 99%

Novel TrueVue series of 3D echocardiography: Revealing the pathological morphology of congenital heart disease

Sun

Chen

et al. 2022

Front. Physiol.

View full text Add to dashboard Cite

Aims: This study explored the advantages and limitations of novel series of three-dimensional (3D) echocardiographic techniques and summarized their application methods for congenital heart diseases (CHDs).Method and result: Two-dimensional (2D), traditional 3D echocardiography, and TrueVue plus light and/or Glass novel 3D technologies were performed on 62 patients with CHD, and a clinical survey was designed to judge whether the novel 3D images were more helpful for understanding the cardiac condition and guide treatment than traditional 3D images. TrueVue increased the visual resolution and simulated the true texture of cardiac tissue, significantly improving the display ability of abnormal anatomical structures in CHDs. TrueVue Glass displayed the blood channel and the internal structure of cardiac cavity more intuitively, indicating a new observation aspect not shown by conventional echocardiography. The clinical survey results showed that the new 3D imaging methods effectively increased the diagnostic confidence of echocardiographers, enabled surgeons to better understand the details of lesions, promoted efficient communication, and improved the confidence of both doctors and patients in treatment.Conclusion: The combined application of TrueVue, TrueVue Light, and TrueVue Glass more closely simulated real anatomical features, showed more comprehensive and subtle blood flow in the lumen, not only increased the visual effect but also provided more useful diagnostic information, improved the accuracy of evaluation and treatment of CHD when compared to traditional imaging techniques, indicating that this combined application has significant clinical value.

show abstract

Section: Discussionmentioning

confidence: 99%

Novel TrueVue series of 3D echocardiography: Revealing the pathological morphology of congenital heart disease

Sun

Chen

et al. 2022

Front. Physiol.

View full text Add to dashboard Cite

show abstract

“…3DTTE/3DTEE may be particularly useful before and during percutaneous VSD closure. [29][30][31] CS is a terrible complication of PIVSD accompanied by a high mortality rate of approximately 89%. 2 Our data suggest that patients who developed VSD and died were more likely to have CS before TCC.…”

Section: Discussionmentioning

confidence: 99%

“…Many analysts now argue 3DTTE/3DTEE has been more successful than 2DTTE for evaluating VSDs following AMI; for example, they argue that the shape of the VSD and its changes during the cardiac cycle can be visually and quantitatively displayed. 3DTTE/3DTEE may be particularly useful before and during percutaneous VSD closure 29–31 …”

Section: Discussionmentioning

confidence: 99%

Transcatheter closure for postinfarction ventricular septal defect: A meta‐analysis of the current evidence

Yang

Wang

et al. 2021

Journal of Cardiac Surgery

View full text Add to dashboard Cite

Objective: Postinfarction ventricular septal defect (PIVSD) is a severe complication of acute myocardial infarction (AMI). Transcatheter closure (TCC) is an alternative option to surgical repair. This study was undertaken to examine the published literature to provide objective evidence for TCC using a meta-analysis. Methods:We searched for significant medical and publisher databases. Two reviewers checked the quality of the studies and extracted data. Eligible studies included single-arm studies and comparative studies. Weighted means, pooled event rates, efficacy outcomes and odds ratios (ORs) for immediate shunt reduction (ISR), presence of cardiogenic shock (CS), New York Heart Association (NYHA) class IV, time from AMI to ventricular septal defect (VSD), and time to VSD closure was estimated.Results: A total of 27 single-arm articles (462 patients) were included. The pooled event rate was 89.7% (95% confidence interval [CI]: 0.772-1.021) for successful device implantation, 80.9% (95% CI: 0.645-0.972) for ISR, 31.5% (95% CI: 0.149-0.482) for 30-day mortality, and 25.3% (95% CI: 0.072-0.434) for 30-day mortality of primary closure at the acute phase. CS (OR = 3.607, 95% CI: 2.301-5.653), NYHA class IV (OR = 6.491, 95% CI: 1.444-29.188) and time to VSD closure were risk predictors for TCC. There was no correlation between defect size (OR = 2.592, 95% CI: 0.380-17.661) and mortality. Conclusion:TCC should be a relatively safe and minimally invasive method for PIVSD, with an excellent successful device implantation rate and acceptable low 30-day mortality. The procedure appears promising, but its safety and efficacy could only be demonstrated by randomized controlled trials. Therefore, the mortality of data comparing surgery to TCC compels the need for future comparative trials.

show abstract

“…Two-dimensional (2D) echocardiography (2DE) underestimates VSD size compared with three-dimensional (3D) echocardiography (3DE) and surgical measures. [1][2][3] We hypothesized that VSD area obtained from 3DE could better discriminate shunt severity than VSD diameters.…”

Section: Ventricularmentioning

confidence: 99%

Ventricular Septal Defect Area by Three-Dimensional Echocardiography for Assessment of Shunt Severity in Children

Hadeed¹,

Guitarte²,

Vincent³

et al. 2021

Journal of the American Society of Echocardiography

Self Cite

View full text Add to dashboard Cite

Assessment of Ventricular Septal Defect Size and Morphology by Three-Dimensional Transthoracic Echocardiography

Cited by 22 publications

References 26 publications

Novel TrueVue series of 3D echocardiography: Revealing the pathological morphology of congenital heart disease

Novel TrueVue series of 3D echocardiography: Revealing the pathological morphology of congenital heart disease

Transcatheter closure for postinfarction ventricular septal defect: A meta‐analysis of the current evidence

Ventricular Septal Defect Area by Three-Dimensional Echocardiography for Assessment of Shunt Severity in Children

Contact Info

Product

Resources

About